Почетна › Занимања › Bioengineers and Biomedical Engineers › Milpitas, CA
Bioengineers and Biomedical Engineers u Milpitas, CA: H-1B plate
22 prijava za uslove rada za ovo zanimanje sa radnim mestom u Milpitas, CA. Medijana ponuđene osnovne plate $125.694; srednja polovina $105.269–$146.576.
По нивоу плата
| Ниво зараде | Медијална плата |
|---|---|
| Ниво I (почетни) | $105.269 |
| Ниво II (квалификовани) | $105.600 |
| Ниво III (искусни) | $146.250 |
| Ниво IV (потпуно компетентни) | $150.000 |
Ministarstvo rada određuje četiri nivoa važeće plate za svako zanimanje i oblast, od Nivoa I (početni) do Nivoa IV (potpuno kompetentan). Poslodavac bira nivo koji odgovara zahtevima posla.
Послодавци
| Послодавац | LCA | Медијална плата |
|---|---|---|
| Becton, Dickinson and Company | 7 | $145.000 |
| Stellartech Research Corporation | 3 | $95.000 |
| N1 Life Inc | 2 | $118.800 |
| Topcon Healthcare Inc. | 2 | $131.750 |
| Augusta Life Sciences US OpCo I LLC | 2 | $127.634 |
| Bigfoot Biomedical, Inc. | 1 | $146.576 |
| Elixir Medical Corporation | 1 | $75.275 |
| VitroLabs Inc. | 1 | $96.000 |
| OBiO Tech, Inc. | 1 | — |
| Galaxy Therapeutics Inc | 1 | $105.000 |
| Tiposi | 1 | $125.694 |
Назив позиције
- Quality Engineer2
- Staff Quality Engineer2
- Senior Systems Design Assurance Engineer1
- Quality Assurance Engineer I1
- R&D Engineer1
- Research Scientist1
- Research Associate1
- Process Development Engineer II1
- Engineering Project Manager, Program Management1
- Staff Engineer I, Systems Verification1
- Senior Application Scientist1
- Research and Development Engineer1
- Research Scientist, Image Processing R&D1
- Senior I, Systems Verification Scientist1
- Senior Global Service Engineer1
H-1B sponzori u Milpitas, CA →
Plate su donja graneta ponuđene zarade po svakoj prijavi, preračunata na godišnji nivo; statistika koristi samo sertifikovane prijave za puno radno vreme. LCA nije odobrenje vize i jedna LCA može pokrivati više pozicija. Izvor: Američki ministarstvo rada, OFLC LCA podaci o otkrivanju, fiskalne godine 2023–2026 (najnovija odluka 30. 6. 2026.).